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Abstract: In this study, we review mechanoregulatory roles for perlecan in load-bearing connective
tissues. Perlecan facilitates the co-acervation of tropoelastin and assembly of elastic microfibrils
in translamellar cross-bridges which, together with fibrillin and elastin stabilise the extracellular
matrix of the intervertebral disc annulus fibrosus. Pericellular perlecan interacts with collagen VI
and XI to define and stabilize this matrix compartment which has a strategic position facilitating
two-way cell-matrix communication between the cell and its wider extracellular matrix. Cues from
the extracellular matrix are fed through this pericellular matrix back to the chondrocyte, allowing it
to perceive and respond to subtle microenvironmental changes to regulate tissue homeostasis. Thus
perlecan plays a key regulatory role in chondrocyte metabolism, and in chondrocyte differentiation.
Perlecan acts as a transport proteoglycan carrying poorly soluble, lipid-modified proteins such as the
Wnt or Hedgehog families facilitating the establishment of morphogen gradients that drive tissue
morphogenesis. Cell surface perlecan on endothelial cells or osteocytes acts as a flow sensor in blood
and the lacunar canalicular fluid providing feedback cues to smooth muscle cells regulating vascular
tone and blood pressure, and the regulation of bone metabolism by osteocytes highlighting perlecan’s
multifaceted roles in load-bearing connective tissues.
Keywords: perlecan: mechanosensation; elastin; fibrillin; PCM stabilization; tissue homeostasis; IVD
biomechanics; mechanobiology; type VI collagen; meniscus
1. Introduction
1.1. Perlecan is a Modular Proteoglycan
Perlecan is a large modular, multifunctional heparan sulphate (HS) proteoglycan (HS-
PG) that is abundant in vascularized tissues but also occurs in poorly and non-vascularized
connective tissues such as articular cartilage, intervertebral disc (IVD), meniscus, liga-
ment and in tendon as a hybrid form, where at least one of its HS glycosaminoglycan
(GAG) chains is replaced by a chondroitin sulphate (CS) chain [1,2] (Figure 1a). Smooth
muscle cells (SMCs) synthesize a CS/HS hybrid form of perlecan whereas keratinocytes
in epithelial tissues synthesize a form containing CS, HS and keratan sulphate (KS) [3],
and endothelial cell perlecan is mono-substituted with HS. Mast cells synthesize perlecan
species with smaller molecular weight core proteins [4] apparently arising from alternative
splicing and/or protease cleavages in the immunoglobulin-rich domain IV, thus generating
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N and C terminal perlecan fragments of variable size. Some of these fragments act as
functional PGs in their own right [5].
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with detected shear forces regulating endothelial membrane polarization, cell prolifera-
tion, cytoskeletal organization and gene expression [7]. Furthermore, this is coupled with 
stimulatory biophysical forces that promote cell differentiation and tissue development 
[8]. Calcium signalling through transient receptor potential (TRP) channels in endothelial 
cells drives vasculogenic processes [9]. TRP channels also regulate the contractile proper-
ties of SMCs to regulate vasodilation and blood pressure [10]. Perlecan, is a mechanical 
biosensor in bone, detecting external loading through the identification of solute move-
ment in the lacuno-canalicular space of the bone matrix [11–13]. 
1.3. The Role of Perlecan in Chondrocyte Mechanotransduction 
Mechanotransduction—the conversion of a mechanical signal to an intracellular re-
sponse—is a crucial process in the homeostatic maintenance of connective tissues such as 
cartilage. Deformation of cartilaginous tissues during normal daily activities exposes the 
chondrocytes to varying stresses, strains, hydrostatic pressure, interstitial fluid flow, elec-
trokinetic effects and ionic changes that alter the local osmotic pressure [14]. Compression 
of the cartilage matrix causes water to be exuded from the tissue, while the negatively 
charged proteoglycans (PGs) are retained and attract positive counter-ions. This phenom-
enon results in fluctuations in the interstitial osmolarity of the ECM and pericellular ma-
trix (PCM) [15,16] which can influence the physiologic activity of the chondrocyte [17,18]. 
In the last ten years, several ion channels, pumps or exchangers have been identified in 
the cell membrane of chondrocytes and shown to have important regulatory roles [19–25]. 
For example, the electrogenic Na+ /K+pump regulates Na+, K+ -ATPase and the resting 
potential of the chondrocyte [21]. Electrochemical gradients of Na+ and K+ are established 
and maintained by this active ATP-requiring pump [26,27]. The presence of Na+ /K+, 
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1.2. Perlecan’s Participation in Physiological Processes
Perlecan also has important regulatory roles in many physiological processes. Perlecan
on endothelial cells in the lumen of blood vessels acts as a dynamic flow sensor [6] with
detected shear forces regulating endothelial membrane polarization, cell proliferation,
cytoskeletal organization and gene expression [7]. Furthermore, this is coupled with
stimulatory biophysical forces that promote cell differentiation and tissue development [8].
Calcium signalling through transient receptor potential (TRP) channels in endothelial cells
drives vasculogenic processes [9]. TRP channels also regulate the contractile properties of
SMCs to regulate vasodilation and blood pressure [10]. Perlecan, is a mechanical biosensor
in bone, detecting external loading through the identification of solute movement in the
lacuno-canalicular space of the bone matrix [11–13].
1.3. The Role of Perleca in Chondrocyte Mechanotransduction
Mechanotransduction—the conversion of a mechanical signal to an intracellular
response—is a crucial process in the homeostatic maintenance of connective tissues such
as cartilage. Deformation of cartilaginous tissues during normal daily activities expos s
the chondrocytes to varying stresses, strains, hydrostatic pressure, interstitial fluid flow,
electrokinetic effects and ion c changes that alte the l cal osmotic pressure [14]. Com-
pression of the c tila e matrix cause water to be exuded from he tissue, whil the
negatively charged proteoglycans (PGs) a e retained and attract positive c unter-ions.
This phenom non esults in fluc ua ions in the interstitial osmolarity of the ECM and
peric llular matrix (PCM) [15,16] wh ch c influence the physiologic activity of t chon-
dr cyt [17,18]. In the last te years, several ion channels, pumps or exchangers have been
identified in the cell membrane of chondrocytes and shown o have important regulatory
roles [19–25]. For example, the electrogenic Na+ /K+pump regul tes Na+, K+ -ATPase
and the r sting potential of the cho rocyte [21]. El ctrochemical gradients of Na+ and
K+ are established and maintained by this active ATP-requiring pump [26,27]. Th pres-
ence of Na+/K+, pump proteins in the c ondrocyte cell membrane have been identifie
using immunological and autoradiographic techniques and multiple α, β, and γ, isoform
subunits identified [28–30]. Proteomic studies on the chondrocyte “surface-ome”, have
confirmed the presence of multiple Na+/K+ pump isoforms [19]. As the ionic environ-
ment around chondrocytes clearly fluctuates during mechanical loading and relaxation
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cycles, chondrocytes have been shown to respond to changes in osmolarity with transient
changes in intracellular Ca2+ that ultimately regulate the cells’ metabolic function and
matrix synthesis [31]. Recent studies suggest that this mechano-osmotic transduction
occurs via interactions of the ion channel transient receptor potential vanilloid 4 (TRPV4), a
non-selective cation channel that is highly expressed in chondrocytes and interacts with the
PCM [32]. The prominent localization of perlecan in the chondrocyte PCM stabilizes this
pericellular environment and may regulate the maintenance of Ca2+ or Na+/K+ gradients
in healthy chondrocytes, disruption of the PCM in arthritic chondrocytes may contribute
to alterations in intracellular signaling and loss of chondrocyte homeostatis [32].
In addition to direct cellular signalling through mechanosensitive ion channels, grow-
ing evidence suggests that the ECM and PCM themselves can play important roles in
transducing physiologic and pathologic mechanical signals in the cellular environment [33].
For example, fibroblast growth factor-2 (FGF-2), a major perlecan ligand, has been shown
to serve as a mechanotransducer in the response of cartilage to trauma. Perlecan and FGF-2
are co-localised within the type VI collagen-rich PCM of articular cartilage. In damaged
cartilage, chondrocytes release FGF-2 resulting in the activation of extracellular signal-
regulated kinases (ERKs) and the induction of chondrocyte regulatory proteins including
TIMP-1 and MMP-1 and 3 [34,35].
Biomechanical measurements conducted on single and groups of chondrocytes show
that in cartilage, when a chondrocyte progresses from a single cell to a string of cells to a
small and then larger cell cluster there is a progressive measurable decrease in stiffness in
the PCM. This relaxation of the PCM makes the enclosed chondrocyte more amenable to
influences from external stimuli from the ECM. The PCM also becomes more susceptible
to proteolytic attack during the pathogenesis of OA [36]. In contrast to the wider, load-
bearing ECM, the PCM contains relatively higher PG levels. Furthermore, small leucine
repeat proteoglycan (SLRP) family members, such as biglycan and decorin, attach to the
type VI collagen of the chondron [37] forming bridging structures between collagen and
aggrecan-and HA networks. Perlecan, discussed in detail below, is also interactive with
type VI collagen in the PCM [38] at all stages of joint development [39–42] contributing to
the unique mechanical properties of the chondron [43]. This collagen-PG interconnectivity
gives rise to coupled mechanosensory networks that extend out of the PCM into the inter-
territorial matrix. These networks allow responsive remote sensing of the extracellular
environment whereby environmental cues (e.g., perturbations in ECM) are fed back to
the chondrocyte that responds appropriately to maintain cartilage homeostasis [44,45].
Collagen-PG networks contribute to the mechano-biology of articular cartilage in health
and disease [46–49].
1.4. Perlecan Operates at Several Functional Levels in Load-Bearing Connective Tissues
Relatively few studies have examined how perlecan impacts on the biomechanical
properties of connective tissues. Perlecan binds type VI collagen in the chondron surround-
ing chondrocytes in cartilage and has cytoprotective properties [38] (Figure 2).
Perlecan also promotes co-acervation of tropoelastin and is found associated with
fibrillin-1, LTBP-2 (latent TGF-β binding protein 2) and a number of accessory elastic
proteins promoting the formation of elastic fibrils at the cell surface [38,51–53] (Figures 3
and 4).
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Figure 2. Perlecan and FGF-2 are prominent components of the PCM of chondrocytes. (a–d) Im-
munolocalisation of perlecan in an adult ovine stifle joint. Left panel: Macroscopic views showing
femoral condyle (a) and tibial plateau (b). Right panel: High power views demonstrating perlecan’s
pericellular distribution in femoral condyle (c) and tibial plateau (d). Figure (a–d) based on data
originally published in [50].
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Figure 3. Perlecan promotes elastin formation by IVD cells. Three-dimensional surface rendered
models of perlecan, elastin and type VI collagen immunolocalization in intervertebral disc tissues,
based on confocal data originally published in [38,54]. Upper panel: Annulus fibrosus cells shown in
(a,b), nucleus pulposus cells in (c,d). Secretion of co-acervated tropoelastin (green) is visible at the
poles of the elongate, spindle shaped annulus fibrosus cells, perlecan label (red) extends outwards
from the pericellular matrix compartment at the cell poles (a,b). In contrast, elastin is only sparsely
distributed around NP cell clusters (c,d). Detail of the elastin labeling (boxed area in (c) is shown in
(d) Arrows denote perlecan foci associated with elastin label in (d). Lower panel: The lower image
(e) shows the overlapping distributions of collagen type VI (green) and pericellular perlecan label
(red) within an annulus fibrosus chondron. Cell nuclei depicted in blue.
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depict microfibrillar material, E amorphous elastin. Arrowheads in (c). depict microfibrils in cross section, whilst arrows 
indicate collagen fibres in cross section. 
Perlecan-elastin and perlecan-elastin-type VI collagen structures contribute to the 
viscoelastic material properties of the composite IVD tissues, particularly the annulus fi-
brosus (AF) [57–60]. Fibrillin-1 and elastin fibrils are also prominent components of trans-
lamellar cross-bridge structures in the IVD which are internal stabilizing structures that 
interconnect multiple, collagen-rich lamellar layers and provideresiliency to this tissue 
[61,62]. Perlecan co-localises with elastin in a number of tissues and with type XI collagen 
Figure 4. Schematic depiction of the elastic microbril, containing perlecan and fibrillin as functional
omponents. (a) Schematic depiction of an elastic microfibril and its components. Electron micro-
graphs of tannic acid-glutaraldehyde-fixed samples demonstrating the central amorphous elastin (E)
within a microfibril in (b) longitudinal (magnification ×18,000) and (c) cross-section (magnification
×85,000); (d) Rotary shadowing images showing the characteristic interrupted globular domains in
type VI collagen. Segment b, c r produced from [55]. Segment d [56] under Open Acce s. Arro s in
(b). depict microfibrillar material, E amorphous elastin. Arrowheads in (c). depict microfibrils in
cross section, whilst arrows indicate collagen fibres in cross section.
Perlecan-elastin and perlecan-elastin-type VI collagen structures contribute to the
viscoelastic material properties of the composite IVD tissues, particularly the annulus
fibrosus (AF) [57–60]. Fibrillin-1 and elastin fibrils are also prominent components of
translamellar cross-bridge structures in the IVD which are internal stabilizing structures
that interconnect multiple, collagen-rich lamellar layers and provideresiliency to this
tissue [61,62]. Perlecan co-localises with elastin in a number of tissues and with type XI
collagen in the PCM of chondrocytes and IVD cells, stabilizing this structure and providing
mechanosensory properties [63] (Figure 5).
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Figure 5. Perlecan interacts with cell surface integrins and type XI collagen in the PCM. (a) Dia-
grammatic schematic representation of the interaction of perlecan with cell surface integrins and
the HSbinding sites of type XI collagen at the ovine disc cell surface. (b,c) Immunoperoxidase
localisation of type XI collagen (b) and perlecan HS (c) in monolayer cultures of annulus fibrosus
cells. (d) Schematic of the HS binding sites on the exposed Npp α1 domain of a type XI collagen
heterofibril (e) Immunofluorescence l c li i i c ltured chondrosarcoma cells
showing pericellular HS-PGs. Segments a-c reproduced from [63]. Segments d and e reproduced
from [64]. All plates in (e) are provided at the same magnification, 20 µm scale bar applicable to all
segments.
Perlecan interacts with α-dystroglycan in muscle tissues and has important roles in
the assembly and function of the motor neuron neuromuscular junction (NMJ). It is a
functional component of the specialized motor neuron synaptic endplate which interfaces
with muscle fibres and controls muscular activity [65–67]. Perlecan also co-localises with
elastin in endotheli l ll i blood ves el basement membranes in vascularized tissue [54]
(Figure 6).
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While the PCM is, in general, highly resistant to enzymatic digestion by chon-
droitinase, aggrecanase, or hyaluronidase [69], enzymatic removal of HS chains from per-
lecan with heparinase III results in increased elastic moduli in the PCM, specifically within 
interior regions of the PCM that are positive for both perlecan and type VI collagen. Inter-
estingly, heparinase III digestion has no effect on the micromechanical properties of the 
ECM. These findings suggest that perlecan plays a biomechanical role in the PCM com-
partment, potentially serving as an additional “integrator” of the various matrix proteins 
focused on this region. Indeed, the fact that intact chondrons can be isolated from mice 
genetically lacking collagen VI suggests that additional matrix macromolecules such as 
perlecan are required to maintain the structural integrity of the PCM. 
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Figure 6. Colocalisation of perlecan and elastin in blood vessels. Confocal immunofluorescence
localisations of perlecan and elastin in the basement membrane of a paraspinal blood vessel from a
14-week-old human foetal spinal specimen (a–d). Perlecan (red) and elastin (green) are colocalised
(yellow) at the lumenal surface of the endothelial cell basement membrane of the blood vessel. The
boxed area in (d) is shown at higher magnification in (e–h). (i,j) Elastin immunolocalisations are also
shown in a additional paraspinal capillary (i) and in a venule (j). Cell nuclei depicted with DAPI
staining (blue). Image reproduced from [54].
From a biomechanical standpoint, the PCM appears to be defined similarly by the
presence of type VI collagen as well as perlecan in both cartilage [43] and meniscus [68].
However, interior regions within the PCM containing both type VI collagen and perlecan
exhibit lower elastic moduli than more peripheral regions that are rich in type VI collagen
alone. The localization of perlecan to low modulus, interior regions of the PCM provides
support for a potential role for HS and perlecan in the mechanical properties of the PCM as
well as the process of mechanotransduction in cartilaginous tissues.
While the PCM is, in general, highly resistant to enzymatic digestion by chondroitinase,
aggrecanase, or hyaluronidase [69], enzymatic removal of HS chains from perlecan with
heparinase III results in increased elastic moduli in the PCM, specifically within interior
regions of the PCM that are positive for both perlecan and type VI collagen. Interestingly,
heparinase III digestion has no effect on the micromechanical properties of the ECM.
These findings suggest that perlecan plays a biomechanical role in the PCM compartment,
potentially serving as an additional “integrator” of the various matrix proteins focused on
this region. Indeed, the fact that intact chondrons can be isolated from mice genetically
lacking collagen VI suggests that additional matrix macromolecules such as perlecan are
required to maintain the structural integrity of the PCM.
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1.5. The Functional Attributes of Perlecan’s Five Domains
1.5.1. Domain-1
Perlecan interacts with several collagens and cell adhesive and structural glycopro-
teins aiding in the organization and stabilization of the ECM and cell-ECM interface. Many
of the collagens (e.g., collagen types IV, XIII, XIV) interact prominently with perlecan within
the basal lamina of blood vessels, the blood–brain barrier, membranous structures sur-
rounding nerves in the peripheral and central nervous systems (PNS/CNS), the meninges
surrounding brain and spinal cord, and around nerve bundles. Some of the collagens
have specific HS binding sites (e.g., collagen types V, XI) and can be incorporated into
heterofibrils with collagen types I and II and this may contribute to microfibril and fibril
bundle assembly in tendons. Fine type XI collagen fibres localize with perlecan in the PCM
around cells and may have stabilizing roles to play in this region [63]. Other ECM proteins,
including PRELP (proline/arginine-rich end leucine-rich repeat protein), WARP (von Wille-
brand factor A domain-related protein), laminin, thrombospondin and fibronectin also
have HS binding sites which contribute to the networking of these components in the ECM.
Col 99 is a transmembrane collagen that is interactive with perlecan found in Caenorhabditis
elegans. CollQ, a collagen-tailed form of acetylcholinesterase is anchored in the NMJ by
perlecan and is essential for motor nerve functional properties at the nerve-muscle interface
which regulates muscular movement and is wired into the CNS allowing co-ordination of
the activity of different muscle groups to control skeletal movement. PRELP is a member
of the SLRP family and acts as an anchorage point for perlecan in many basement mem-
branes [70]. WARP is another perlecan-interactive protein that has stabilizing properties in
specialized membranous tissues surrounding nerves [71]. Perlecan interacts with collagen
type VI in the PCM of tensional and weight bearing connective tissues (e.g., cartilage, IVD
and meniscus) where it provides compliant and cyto-protective properties [38,43]. Perlecan
also aids in the co-acervation of tropoelastin at the cell surface and in the assembly of
a fibrillin scaffold around these nascent molecular structures to form elastic microfibrils
which provide mechanosensory properties to the cells they are attached to [54].
1.5.2. Domain II
Perlecan domain II binds fibrillin-1, lipoproteins, and lipids. Excessive build up of
these components on endothelial cells at the luminal surface of blood vessels contributes to
atherosclerotic plaque formation. This is balanced by the ability of perlecan to clear lipids
from the blood stream and their endocytosis by the vessel endothelium. Domain II acts as
a low-density lipoprotein (LDL) receptor and binds Wnt and hedgehog proteins which are
lipid-modified proteins of limited solubility in aqueous media. This aids in the transport
of these proteins and also facilitates formation of biochemical gradients that drive tissue
development and morphogenesis.
1.5.3. Domain III
WARP binds to perlecan domain III. WARP has a restricted expression in the perma-
nent cartilages and a distinct subset of basement membranes in peripheral nerves, muscle,
and CNS vasculature. Besides binding to perlecan, WARP also binds to type VI collagen,
and may act as a bridging structure between protein networks in connective tissues [71].
Collagen type VI also binds to perlecan domain III, as does tropoelastin, suggesting that this
domain may promote the formation of elastic microfibrils with mechanosensory functions.
1.5.4. Domain IV
Human perlecan domain IV contains 21 immunoglobulin G repeats, sharing homology
with NCAM, and it also contains a novel peptide sequence that supports cell adhesion,
spreading and activation of the FAK (focal adhesion kinase) cell signaling pathway [72].
Domain IV is the largest of perlecan’s domains and it acts as a template for the attachment of
a number of ECM-stabilising proteins including, nidogen-1 and 2, fibronectin and collagen
types IV and VI, thus it has a prominent role to play in ECM stabilisation [73,74]. Domain IV
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is also susceptible to degradation by a number of MMPs and serine proteases. The domain
IV fragmentation pattern evident in various stages of prostate cancer may have utility as
a biomarker of disease progression [75]. It has also been suggested that degradation of
domain IV converts it from a tumour-inhibitory form to one which is ‘tumour-friendly’ [76].
1.5.5. Domain V
Domain V is composed of three laminin G domains which are each separated by
two EGF-like domains. Domain V interacts with a number of ECM-stabilising proteins
(nidogen-1, fibulin-2, ECM-1, collagen type VI), however the major interest of domain V
lies in its angiogenic properties which have been proposed as a prospective therapeutic to
treat ischaemic stroke [77,78]. Fragments of domain V containing the LG1-LG2 domains or
LG3 domain can block VEGFA (vascular endothelial growth factor A) activity or binding
to α2β1 integrin providing anti-angiogenic activity. A GAG attachment site has also been
identified in the LG3 domain but it is not always occupied [79].
1.6. Fibrillin-1 Stabilizes Tissues and Provides Essential Functional Properties
Fibrillin-1 is a fibrillar 350 kDa calcium-binding protein that has a widespread distri-
bution in connective tissues occurring in assemblies of 10–12 nm microfibrils. Fibrillin 1-3
contain two types of disulfide-rich motifs, the calcium-binding epidermal growth factor-
like (cbEGF) and transforming growth factor beta binding protein (TGFBP)-like domains
as dominant functional determinants. Elastin and fibrillin-1 are building blocks for elastic
fibers that support the mechanical stabilisation of tissues [80]. Fibrillin microfibrils provide
biomechanical properties to tissues endowing them with limited elasticity and durability
and these act as templates for elastin deposition during elastic fibre assembly [81]. Re-
cent evidence suggests that tropoelastin initially undergoes assembly within the cell or at
unique assembly sites on the plasma membrane to form elastin aggregates (Figure 3a,b),
which, when outside the cell, transfer to fibrillin scaffolds-tensional forces transmitted
through these structures then help to shape the growing microfibril [82] (Figure 4c,d). The
recent identification of intracellular perlecan in IVD cells suggests potential roles in this
aggregation process, and is consistent with roles ascribed to HS in the initial stages of
the co-acervation of tropoelastin [83,84]. Knock-out studies in mice have also shown that
accessory proteins such as fibulin-4, -5 and LTBP-4 also play crucial roles in the elasto-
genic process [85]. Elastic microfibrils also represent a storage niche for growth factors in
tissues, mutations in fibrillin cause Marfan syndrome and short-stature pathologies due
to dysregulated growth factor signalling. Thus while elastin-fibrillin microfibrils have
mechanosensory roles in tissues they also have major regulatory functional roles in growth
factor regulation [86] (Figure 4b).
1.7. Interactive Properties of Perlecan, Assembly of Elastic Microfibrils and Their Functional
Attributes
Confocal studies have demonstrated that perlecan in the PCM of AF cells promotes
the co-acervation of tropoelastin synthesised by this cell type [52–54]. A quartz crystal
microbalance study also demonstrated the de novo assembly of elastin on a quartz crys-
tal coated with perlecan in vitro [54]. Fibrillin-1 fibrils are also assembled at the AF cell
surface surrounding the coacervated elastin to form a composite elastin-fibrillin fibril
as found in many other connective tissue cell types (Figure 4c,d). These elastic fibrils
are found co-distributed with collagen fibrils including type VI collagen and versican
and are also attached to cell-associated perlecan in the annular tissues. Cells of the AF
and nucleus pulposus of the IVD possess a PCM rich in type VI collagen, similar to
that of articular cartilage, which plays a crucial role in the transmission of mechanical
signals from the surrounding environment of the cells [87–89] (Figure 3). The AF under-
goes both tension and compression in the composite IVD tissues. Perlecan also colocal-
izes with elastin and fibrillin-1 in blood vessels [54]. These observations are consistent
with published studies identifying HS as a component of early microfibril assembly [84]
and the linkage of fibrillin fibril bundles with other connective tissue networks by ver-
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sican [90]. Fibronectin serves a similar role in the assembly of elastic fibrils with other
cell types [91,92] and governs the deposition of LTBP in tissues [93]. Elastic microfibrils
are not only structural determinants in tissues but also play mechanosensory roles that
allow cells to maintain tissue homeostasis [94,95]. Elastic microfibrils are also repositories
for growth factors that have roles in tissue development and morphogenesis [96,97]. The
fibrillin microfibril scaffold contains a number of associated proteins and growth factors,
e.g., transforming growth factor-β (TGF-β), bone morphogenetic proteins (BMPs) etc,
thus these are mechano-responsive structures capable of feeding mechanosensory signals
back to cellular receptors through the fibrillin fibril extracellular network [97–99]. This
complex interchange of information regulates tissue homeostasis and development and
growth [94–96]. Abnormal functioning of this system is evident in Marfan’s Syndrome and
other pathological conditions of short stature.
1.8. The Pericellular Matrix, a Dynamic Cell-Matrix Interface
The PCM is a key region in tissues, representing an interactive interface between cells
and their biomechanical micro-environment [100]. The PCM also protects cells in hostile
weight-bearing environments [63,101]. Perlecan plays essential cyto-protective roles in the
PCM as perlecan knockdown severely impacts PCM organisation, composition and func-
tional properties [102] (Figure 2c,d). A structurally impaired PCM results in mechanical
overload to the chondrocyte and cell death [103]. Loss of spatial organisation and destruc-
tion of the PCM in articular cartilage occurs in osteoarthritis (OA) [104] and is a hallmark
of the degenerative processes that lead to the development of this joint disease [105,106].
Micromechanical mapping of early changes in the chondrocyte PCM in OA, atomic force
microscopy (AFM) [107,108] and multiphoton microscopy [109] have demonstrated the
importance of the correct structural organisation and mechanotransductive pathways
in chondrocyte regulation in the maintenance of tissue homeostasis [110–112]. Perlecan
interacts with collagen types VI and XI and a number of cell adhesive and structural glyco-
proteins to stabilise the PCM of the chondrocyte [32,38,63,113], and enzymatic digestion of
perlecan alters the biomechanical properties of its PCM [43]. Perlecan is also a component
of basal laminar structures and blood vessels in the synovium and paraspinal tissues
(Figure 6). Confocal reconstructions of AF cells and articular chondrocytes labelled for
perlecan and collagen type VI show the overlapping pericellular localisations of perlecan
and collagen type VI within the chondron structure (Figure 3e). While perlecan has a
pericellular distribution around chondrocytes in the rudiment and growth plate cartilages
it also has an extracellular distribution in these tissues during morphogenetic change with
tissue development. This contrasts with the highly focussed PCM distribution of perlecan
around articular chondrocytes of mature cartilage tissues, i.e., with no detectable perlecan
within the interstitial and inter-territorial ECM, as once formed, these permanent cartilages,
once formed, do not undergo further morphogenesis (Figure 2c,d). Perlecan is also found in
translamellar cross bridge structures within the IVD having a polarized distribution at the
ends of strings of fusiform AF (Figure 3) and ligament cells and being surrounded by linear
arrays of fibrillar collagen. Furthermore, in the meniscus, perlecan has PCM and ECM
distributions similar to that of chondrocytes found in growth plate cartilage [114]. Thus,
as the precise spatio-temporal distribution of perlecan differs in particular cartilaginous
tissues, its realms of influence varies accordingly.
1.9. Elastic Networks in Load-Bearing Connective Tissues
As mentioned above, perlecan interacts with a number of ECM components to stabilize
tensional and weight bearing tissues such as articular cartilage and IVD. Perlecan interacts
with fibrillin-1 and elastin in the AF of the IVD (Figure 7) and in translamellar cross-bridge
structures across many lamellar layers [62] (Figure 5). Type VI collagen is also a prominent
component of these structures and has been shown to interact with perlecan associated
with elastic microfibrils [38,61].
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While elastin is a well-known component of tissues such as lung and blood vessels,
endowing these tissues with the elasticity necessary for their physiological functions, recent
research has also revealed the existence of extensive networks of fine elastin fibres in tissues
such as articular cartilage and the IVD [115,116]. Microfibrillar elastic networks are evident
in bovine and human IVDs. In the outer AF of the IVD, these are organized into parallel
microfibril bundles in the interterritorial matrix, co-localized with elastin fibres and aligned
parallel to collagen fibres [116]. Fibrillin-1, fibrillin-2 and LTBP-2 are also found associated
with these fibrillar networks [117] and contribute to the mechanical properties of these
structures (Figure 7). An elastin rich basal lamina is also present in the endothelium of the
knee joint (Figure 8).
The importance of microfibrillar elastic networks in biomechanical function can be
seen across musculoskeletal connective tissues of different organisms and joints.
Figure 9 shows elastin fibres distributed in kangaroo knee tibial articular cartilage [118,119].
The kangaroo is a high-performance athletic animal that can maintain a comfortable hop-
ping speed of between 20 to 25 km/h but it can move at speeds of up to 70 km/h over short
distances, and can maintain a speed of 40 km/h for nearly 2 km. Thus, the elastic fibres
observed in kangaroo knee articular cartilage are expected to make a significant mechanical
contribution to the rebound performance of its articular cartilages. Femoro-tibial kangaroo
cartilages also have well defined collagen fibre networks which contribute to the high
mechanical performance of these tissues [120]. Extensive elastic fibrillary networks are
also present in bovine articular cartilage, which is a more sedentary animal [121]. Tem-
poromandibular cartilage also has an extensive arrangement of elastic fibres and these are
even found in flexor tendon [122–124], a tissue considered to be inextensible and designed
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for force transmission. Elastic fibres are also major components of the deformable elastic
cartilages found in the outer ear (pinna), nose, larynx, trachea, ligaments and vascular
endothelium and contribute significantly to their flexibility.
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Confocal localisation of perlecan (b, red), elastin (c, green), DAPI-stained cell nuclei (d) and 
merged image showing colocalisation of perlecan and elastin (e, yellow) within an elastic lamina 
and surrounding a synovial blood vessel.  The arrows indicate the surface of the synovium.The 
asterisk indicates a blood vessel in the synovium. Figure reproduced from [54] with permission. 
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for force transmission. Elastic fibres are also major components of the deformable elastic 
cartilages found in the outer ear (pinna), nose, larynx, trachea, ligaments and vascular 
endothelium and contribute significantly to their flexibility. 
Figure 8. l l ti t f l l ina in the knee joint endothelium. (a)
ae atoxylin & eosin stained tissue section of an 18 month old ovine knee synovium specimen.
Confocal localisation of perlecan (b, red), elastin (c, green), DAPI-stained cell nuclei (d) and merged
image showing colocalisation of perlecan and elastin (e, yellow) within an elastic lamina and sur-
rounding a synovial blood vessel. The arrows indicate the surface of the synovium.The asterisk
indicates a blood vessel in the synovium. Figure reproduced from [54] with permission.
Correlation of the type VI collagen and perlecan immunolocalization patterns around
articular chondrocytes (Figure 10) and meniscal cells (Figure 11) with focal biomechanical
data obtained from AFM show that both molecules contribute to the biomechanical func-
tional properties of these tissues (i.e., articular cartilage and meniscus). The elastic fibrils
present in these tissues would also be expected to have roles in their resilience and visco-
elastic properties, thus complimenting those of perlecan and collagen type VI. This study
demonstrates that perlecan and elastin co-localise in many connective tissues and that type
VI collagen fibres are frequently deposited parallel to the elastin fibres (Figures 3–8 and
10). This suggests the likelihood of cooperative interactions between these components
in order to facilitate the demanding material properties required to resist tensional and
compressive biomechanical loads.
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0.005 as compared to either PCM definition). (f) Regions that were dual-labeled for type VI collagen 
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lage. (a–c) Dual immunofluorescence labeling of type VI collagen (a, red), and perlecan (b, green) within the pericel-
lular matrix compartment of articular cartilage. The adjace t overl y image (c) shows their overlapping distributions.
Scale bar = 5 µm. (d) Contour map of the calculated elastic moduli for the pericellular matrix region shown in (a–c), as
determined by AFM scanning. (e) Elastic moduli of cartilage extracellular matrix (ECM) and pericellular matrix (PCM)
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within the meniscus, meniscal tissue samples were cryosectioned and immunofluorescently labeled
for perlecan, which has been shown previously to be localized to this matrix compartment within the
meniscus [114]. PCM and ECM properties were evaluated as described previously [43] with PCM
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perlecan staining. Force maps of 20 × 20 µm pericellular regions within each meniscus region (top
row) were integrated with fluorescent perlecan staining (middle row) to define PCM boundaries.
The resulting PCM force maps were analysed to yield an average elastic modulus (g–i). Figure
reproduced from [68] with permission.
2. Conclusions
A vast amount of literature has elucidated perlecan’s roles as a vascular HS-PG.
However, with the identification of perlecan in non-vascularised tissues, such as articular
cartilage, meniscus, and IVD, its roles in ECM organization and stabilization in tensional
and weight-bearing connective tissues has become apparent. ECM networks assembled by
cells consisting of perlecan-elastin and perlecan-elastin-collagen type VI assembled by cells
are both strong and compliant and contribute to the visco-elastic material properties of
tensional and weight-bearing connective tissues. Perlecan is an important component of the
PCM and has roles in the assembly and function of structures which connect the cell with
its pericellular microenvironment. The PCM is a mechanosensory structure that provides
cues to cells which respond appropriately to fluctuations in their microenvironment to
maintain tissue homeostasis. Perlecan facilitates the coacervation of tropoelastin and its
incorporation with fibrillin-1 in elastic microfibrils at the cell surface. Perlecan also co-
localizes with elastin in blood vessels and in the endothelium of synovial joints and has
interactive properties with the collagen types VI and XI networks in the PCM of articular
cartilage and IVD. Data suggests that perlecan provides a level of compliance to the
relatively rigid collagen type VI chondron structure and confers a cytoprotective property.
Perlecan is an outstandingly versatile PG in terms of the numbers of physiological processes
it regulates and the important functional roles it plays in a variety of different connective
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tissues. The mechanosensory and neurosensory processes outlined in this review illustrate
another chapter in the functional repertoire of this fascinating multifunctional HS-PG.
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